[Wünderlich syndrome in patient anticoagulated with dabigatran].
José H
JH
de Gea-García
Manuel
M
Alvarez
Genoveva
G
Ruiz-Villa
José D
JD
Jiménez-Parra
D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D001562:Benzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D002545:Brain Ischemia / Q000150:complications; D002295:Carcinoma, Transitional Cell / Q000150:complications / Q000601:surgery; D000069604:Dabigatran; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D006406:Hematoma / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D009392:Nephrectomy; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications; D012187:Retroperitoneal Space; D014057:Tomography, X-Ray Computed; D001749:Urinary Bladder Neoplasms / Q000150:complications / Q000601:surgery; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran